On November 24, accompanied by LI Jingyu, Drug Safety Director of Zhangzhou Market Supervision Administration, Xu Ming, Secondary Investigator of Taiwan Investment Zone Administrative Committee, and Lin Limei, director of Xiamen Drug Inspection Office, Zhang Wenchun, member of Party Group and Deputy Director of Fujian Food and Drug Administration, Li Xiaoqiong, director of Cosmetics Supervision Department of Fujian Food and Drug Administration, together with their party, visited the Company for investigation. Lin Jianping, General Manager, Wang Zhenhua, Vice President of Administration, and Chen Linlin, director of the QA Department, all accompanied the investigation.

Deputy Director Zhang and Director Li, together with their party, listened to the introduction to the Company’s development history, future planning and product research and development. They fully affirmed our innovations, particularly the amazing bold organic combination with local characteristics, which greatly contributes to enhancing the local awareness and economic development, and positively praised our active participation in public welfare charity, initiative assumption of social responsibilities and promotion of enterprise party building. For the existing obstacles and difficulties, they also made the enthusiastic and professional responses on spot, and publicize the spirit of the 20th Party Congress, hoping that under the framework of new laws and regulations, we could break through the difficulties for the further development, and make greater contributions to cross-strait integration as a Taiwan-funded enterprise.

(Source: Fujian Food and Drug Administration at: https://yjj.scjgj.fujian.gov.cn/zwgk/xwdt/sjdt1/202211/t20221130_6066074.htm）